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Smoking is a highly prevalent modifiable risk factor for many pulmonary, cardiovascular, and additional systemic diseases. Smoking is also known to be a risk factor for the development of ocular vascular disorders, such as hypertensive retinopathy, age-related macular degeneration, and anterior ischemic optic neuropathy.[@ref1][@ref2] In particular, smoking is associated with anatomic alterations in both the microvasculature and macrovasculature.[@ref1][@ref3]

Smoking impacts vascular endothelium by increasing oxidative stress, decreasing antioxidant vitamin C, and inducing an abnormal nitric oxide activity.[@ref4] Previous studies have shown that smokers have decreased blood flow in retinal and optic nerve head veins because of increased vascular resistance.[@ref5][@ref6][@ref7]

Optical coherence tomography angiography (OCTA) is a new non-invasive imaging technique that uses motion-controlled contrast imaging to provide high-resolution volumetric blood flow information. It is helpful for analyzing the retinal microvasculature without dye injection. OCTA is able to separately visualize superficial (SCP) and deep capillary plexus (DCP).[@ref8]

Previous studies have reported that retinal blood flow alters in smokers.[@ref1][@ref9][@ref10][@ref11] However, these studies are limited by number, and they do not report alterations in long-term smokers. In this study, we aimed to investigate the effect of smoking on the foveal avascular zone (FAZ) and vessel density (VD) in the SCP and DCP using OCTA in long-term smokers.
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=====================

This cross-sectional study examined healthy age- and sexmatched participants. Fifty non-smokers and 50 chronic, regular smokers were included. This study was performed in adherence with tenets of the Declaration of Helsinki and was approved by our ethics committee. Informed consent was obtained from all study participants. The study group consisted of subjects coming to the ophthalmology clinic for routine ophthalmologic examination.

The following exclusion criteria were applied: history of ocular surgery, glaucoma, uveitis, age-related macular degeneration, retinal dystrophy, any systemic disease such as diabetes mellitus, hypertension, and current use of medication. The inclusion criteria were as follows: smokers who had been smoking for at least five years, aged 35-55 years, having \<3 D of spherical and \<1 D cylindrical refractive error, \<25 mm axial length, no history of ocular disease, normal blood pressure (\< 140/90 mmHg), normal blood parameters (e.g. blood sugar, cholesterol levels). Non-smokers lived in smoke-free homes. Additionally, inclusion criteria were sufficiently clear ocular media, and adequate pupillary dilation and fixation to permit quality OCTA imaging.

A detailed ophthalmic examination was performed. Spectral domain optical coherence tomography systems (SD-OCT) (Retina Scan RS 3000 Advance, Nidek Inc, Gamagori, Japan) was used to measure the central retinal thickness (CRT). We captured the OCT scans using the macula line 12-mm horizontal scan. The scans consisted of 1024 A-scans with high definition. Each image consisted of 120 averaged B-scans, with a 4-μm resolution. Before imaging, each subject\'s pupils were dilated with tropicamide and phenylephrine. OCTA (Optovue RTVue XR Avanti; Optovue Inc., Fremont, California; Software version is 2017.1.0.151) was used for macular retinal vascularization assessment. AngioVue uses the split-spectrum amplitude-decorrelation angiography (SS-ADA) algorithm to detect erythrocyte movement. When using this software, it makes it possible to non-invasively visualize the retinal and choroidal vasculature via motion contrast. Each OCTA volume was acquired in 3 s, and two orthogonal OCTA volumes were acquired to perform motion correction to minimize motion artifacts due to microsaccades and fixation changes. FAZ area (mm^2^), superficial foveal and parafoveal VD (%), and deep foveal and parafoveal VD (%) were evaluated. This instrument has an A-scan rate of 70,000 scans per se cond, uses a light source centered on 840 nm, a bandwidth of 45 nm, and axial resolution of 5 mm.

After setting the image scale to 3 mm x 3 mm in the software parameters, automated FAZ boundary detection is provided by the AngioVue software, applied on retina slab \[inner limiting membrane (ILM) to outer plexiform layer (OPL) +11~\'\'~μm\], and can be reviewed on the en face screen, under "FAZ" measurements.

The \'en face\' image was then automatically segmented to define the SCP and DCP using the built-in software segmentation algorithm. The en face images of the SCP were segmented with an inner boundary of the ILM and an outer boundary at 11 μm beneath the inner plexiform layer (IPL). The en face images of the DCP were segmented with an inner boundary 11 μm beneath the IPL and an outer boundary at 11 μm beneath the OPL.

Parafoveal VD was calculated for the ring-shaped area between a 1 mm and 3 mm from the center of the fovea. Parafoveal VD was defined as the percentage of total area occupied by vessels and microvasculature, and was quantified in the SCP and DCP. To calculate the VD, the AngioVue Analytics software was used to extract a binary image of the blood vessels from the grey-scale OCTA image, and then the percentage of pixels with flow signal greater than the threshold in the defined region was calculated.

Image quality was assessed for all OCTA scans. Patients who were not co-operative with OCTA were not included in the study. Poor quality images (defined as scan quality \<6/10 or presence of significant artifact) were excluded. Projection artifact removal algorithm is available in this version of AngioVue software. In patients with multiple available OCTA images, the one with the highest scan quality was used for analysis. Segmentation errors, if present, were corrected manually in each patient.

All OCTA scans were performed at the same time of the day (in the morning) to avoid diurnal fluctuations. All scans were performed by the same technician.

The smokers were divided into two groups according to smoking in pack-years \[pack-years = packs (20 cigarettes) smoked per day x years of smoking\], (smokers less than 10 pack-years and more than 10 pack-years) and then compared with each other.
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### Statistical analysis {#sec3-1}

Statistical analyzes were performed using the Statistical Package for the Social Sciences software version 21.0 (IBM Inc. Chicago, IL, USA). The Shapiro-Wilk test was used to assess the appropriateness of calculations to normal distribution. The Mann-Whitney U test was used for variables that did not show normal distribution. A 5% level of significance was adopted; therefore, results with a *P* value \<0.05 were considered statistically significant.
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=====================

Fifty smokers and 50 healthy non-smokers, as a control group, were recruited for the study. The smoker group consisted of 32 males (64%) and 18 females (36%), and the control group was comprised of 35 males (70%) and 15 females (30%). The mean age of the smokers group and control group was 48.47 ± 4.6 (range, 35--55) years and 44.07 ± 7.3 (range, 35--55) years, respectively. There were no significant differences between the smokers and non-smokers in the measurements of age, sex, spherical equivalent, axial length, and CRT \[[Table 1](#T1){ref-type="table"}\].

###### 

The demographics features in the smoker and non-smoker group

                             Smoker (*n*=50)   Non-smoker (*n*=50)   *P*
  -------------------------- ----------------- --------------------- -------
  Age (years)                48.47±4.6         44.07±7.3             0.085
  Gender (male/female)       32/18             35/15                 0.445
  Spherical equivalent (D)   0.4±1.8           0.4±1.6               0.795
  Axial length (mm)          23.2±0.6          23.3±0.4              0.625
  CRT (mm)                   195.5±14.3        186.8±12.8            0.596

CRT: Central retinal thickness

The mean duration of smoking in smokers was 12 ± 2.5 (range, 5-15) years. The mean packs-per day of smoking was 1.3 (range, 0.5-2). Evaluation of OCTA findings: the FAZ area was 0.424 ± 0.100 mm^2^ in the smokers group and 0.333 ± 0.093 mm^2^ in the non-smoking control group (*P* = 0.002). Superficial foveal VD was 32.22 ± 4.70% in the smokers group and 34.43 ± 6.05% in the non-smoking control group (*P* = 0.120). Deep foveal VD was 31.76 ± 6.33% in the smokers group and 53.09 ± 5.88% in the non-smoking control group (*P* = 0.006) \[[Table 2](#T2){ref-type="table"}\].

###### 

The measurements in the smoker and non-smoker groups

                                  Smoker (*n*=50)   Non-smoker (*n*=50)   *P*
  ------------------------------- ----------------- --------------------- ---------
  Age                             48.47±4.6         44.07±7.3             0.085
  FAZ area (mm^2^)                0.424±0.100       0.333±0.93            0.002\*
  Superficial foveal VD (%)       32.22±4.70        34.43±6.050           0.120
  Superficial parafoveal VD (%)   54.12±4.25        54.15±3.44            0.337
  Deep foveal VD (%)              31.76±6.33        53.09±5.88            0.006\*
  Deep parafoveal VD (%)          62.97±3.90        63.09±5.88            0.287

\*Statistically significant. FAZ: Foveal avascular zone, VD: Vessel density

When the parameters were evaluated according to the amount of smoked pack years (\<10 pack-years, \>10 pack-years), the FAZ area, superficial foveal VD, and deep foveal VD were statistically different between the groups (*P* = 0.005) (*P* = 0.021) (*P* = 0.012), respectively \[[Table 3](#T3){ref-type="table"}\].

###### 

The measurements in the smoker group

                                  Smoker       *P*          
  ------------------------------- ------------ ------------ ---------
  Age                             44.30±4.5    47.65±3.8    0.072
  FAZ area (mm^2^)                0.368±0.77   0.479±0.09   0.005\*
  Superficial foveal VD (%)       34.24±4.74   30.19±3.81   0.021\*
  Superficial parafoveal VD (%)   54.10±4.72   54.13±3.89   0.935
  Deep foveal VD (%)              34.73±6.38   28.80±4.83   0.012\*
  Deep parafoveal VD (%)          62.53±4.54   63.41±3.24   1.000

\*Statistically significant. FAZ: Foveal avascular zone, VD: Vessel density
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In this study, we investigated the effects of smoking on the macular microvasculature in at least 5 years in chronic, regular smokers.

Cigarette smoking has been linked with many vascular alterations, including experimental evidence of altered retinal and choroidal blood flow and endothelial reactivity.[@ref12][@ref13]

Rose *et al*. observed that smokers exhibited reduced retinal vascular reactivity to normoxic hypercapnia compared with healthy controls.[@ref10] Cigarette smoking has been associated with low blood velocity of the ophthalmic artery.[@ref14] Sızmaz *et al*. found a significant decrease in choroidal thickness due to smoking. They considered that this decrease could be associated with decreased blood flow to the choroid following smoking.[@ref2]

Nicotine and vasoactive components present in cigarettes may cause an increase in choroidal vascular resistance by inducing vasospasm in the circulatory system and may cause anterior ischemic neuropathy as a result of construction of posterior ciliary arteries.[@ref15][@ref16]

Cigarette smoke contains a myriad of potential toxic and systemic vasoconstrictive compounds including nicotine during exposure.[@ref17] Smoking appears to impair endothelial cell function in many vascular regions, and evidence supports long-term vasoconstriction and altered endothelial response.[@ref18][@ref19][@ref20] Substances in cigarette smoke have additionally been demonstrated to induce direct oxidative damage to the endothelium.[@ref21][@ref22]

One of the metabolites that cigarettes contain is carbon monoxide (CO). CO causes a decrease in the transport capacity of hemoglobin for oxygen and organ oxygenation because hemoglobin has a greater affinity for CO than oxygen. A decrease in the perfusion and oxygenation of the microvascular system leads to the formation of an abnormal hemodynamic environment, which is a pathogenetic factor in the development of retinopathy.

In this study, we assessed FAZ, foveal and parafoveal vessel densities in the SCP and DCP in individuals who were regular smokers for at least 5 years and compared the results with non-smokers. In the smokers group, we found significant enlargement of the FAZ area and a significant decrease in deep foveal VD. There was no significant difference between the groups according to the superficial foveal VD and parafoveal VD.

Multiple properties, including the distance from the larger arterioles, and the proximity to the high metabolic demand of the outer retina and the complex vascular anatomical architecture may make the DCP more susceptible to damage.[@ref23]

When we made an assessment based on the amount of cigarettes smoked, we found a significant decrease in the FAZ area and both the superficial and deep foveal VD in individuals who smoked more than 1 pack per day. As the amount of smoking increases, there is a decrease of superficial foveal VD, in addition to deep foveal VD.

OCTA has the potential to provide objective automated evaluation of the vascularity of the superficial and DCP. There are numerous studies in the literature showing changes in vascular density using OCTA in patients with diabetes which mostly show a reduction of vascular density and enlargement of the FAZ.[@ref24][@ref25][@ref26][@ref27][@ref28][@ref29]

FAZ enlargement can be detected using fundus fluorescein angiography (FFA). However, smoking is not an indication for FFA imaging, so it was not possible to evaluate the FAZ in the smokers using this method. However, it is possible with OCTA, which is a reliable, rapid technique and does not require dye injection. OCTA offers the opportunity to quantitatively assess microangiopathies caused by cigarette smoking.

There is a study in which the effect of smoking on the eye was assessed using OCTA. Ayhan *et al*. showed that smoking caused a significant decrease in the blood flow index of choriocapillary area by the acute effects of nicotine, as evaluated using OCTA.[@ref11]

FAZ dimension has a strong positive correlation with the severity of capillary non-perfusion in several retinal vascular diseases.[@ref30] Studies using FFA to analyze FAZ dimension demonstrated large variability in healthy subjects.[@ref31][@ref32] Mastropasqua *et al*. reported excellent reproducibility and repeatability of FAZ area measurements in normal eyes using OCTA.[@ref33]

Ciesielski *et al*. investigated in their study the acute effect of smoking on FAZ, parafoveal VD, and peripapillary VD with OCTA. They reported that no immediate influence of smoking on vessel density parameters measured by OCTA in healthy habitual smokers.[@ref34]

The current study had some limitations. It remains unclear whether there is a linear dose effect of smoking on the retinal blood flow. Because of variations in the amount of nicotine per cigarette, the number of cigarettes consumed daily, and the amount of smoke actually inhaled, it may be difficult to examine in detail the dose-dependent effect of smoking on the retinal circulatory parameters in a clinical investigation. We could not evaluate the acute effect of smoking, which may have had an impact on outcomes. Caffeine and alcohol consumption before the measurements were not questioned. We used only one OCTA device in our study. The results were interpreted according to one OCTA device.

In conclusion; in this study, we used OCTA to demonstrate automated quantification of the FAZ and VD of the SCP and DCP in chronic, regular smokers and non-smokers. Our data suggest that smoker\'s eyes exhibit impairment of retinal microcirculation in the macula, especially in the fovea. It has shown that there is an enlargement of the FAZ and reduction of foveal VD of the SCP and DCP in the eyes of smokers compared with those of non-smoking healthy adults. The underlying pathophysiology of FAZ enlargement may be related to capillary non-perfusion and microinfarcts. We think that this situation develops as a result of the deterioration and reduction of blood flow through the effects of smoking. When we compared the amount of cigarettes consumed per day, we found that as well as the DCP, the SCP was beginning to be affected. As the amount of smoking increases, there is a decrease of foveal VD of both the SCP and DCP. It is possible to say that DCP is more susceptible to oxidative damage and poor perfusion caused by cigarette smoking as it is closer to the outer retina due to its high metabolic activity and complex vascular structure. Therefore, we think that the DCP is initially reduced, and as the amount of smoking increases, the SCP is also decreased due the severity of the damage. Furthermore, larger studies that investigate the long-term effects of smoking on retinal microcirculation in the macula may help explain the role of smoking as a risk factor on systemic vascular diseases such as diabetic retinopathy progression.
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